Inducing Local Immune Tolerance to Cure Type 1 Diabetes with Dr. Anthony Japour iTolerance TRANSCRIPT
Download PDFAug 25, 2022
Dr. Anthony Japour is the Chief Executive Officer and President at iTolerance, an early-stage privately-held regenerative medicine company. Currently, if a patient receives a pancreatic islet transplant to treat type 1 diabetes, there is a need for lifelong immune suppression. The technology that iTolerance is...
Aug 25, 2022
Dr. Anthony Japour is the Chief Executive Officer and President at iTolerance, an early-stage privately-held regenerative medicine company. Currently, if a patient receives a pancreatic islet transplant to treat type 1 diabetes, there is a need for lifelong immune suppression. The technology that iTolerance is...
Impact of Increased Steps on the Reduction of Risk for Type 2 Diabetes with Dr. John Bellettiere UCSD and Alexis Garduno UCSD/SDSU Doctoral Student TRANSCRIPT
Download PDFApr 25, 2022
Dr. John Bellettiere is the assistant professor of epidemiology at the Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego. Alexis Garduno is a third-year student in the UC San Diego and San Diego State University joint doctoral program in public health and the first author in a...
Apr 25, 2022
Dr. John Bellettiere is the assistant professor of epidemiology at the Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego. Alexis Garduno is a third-year student in the UC San Diego and San Diego State University joint doctoral program in public health and the first author in a...
New Oral Treatment for Metabolic Diseases Diabetic Retinopathy and Diabetic Macular Edema with Dr. Brian Roberts Rezolute TRANSCRIPT
Download PDFMar 22, 2022
Dr. Brian Roberts is a Senior VP and Head of Clinical Development at Rezolute which is developing first in class therapies in the treatment of metabolic diseases. In addition to working on a therapeutic for congenital hyperinsulinism, a rare disease, Rezolute is also in clinical trials with RZ402, an oral small molecule...